These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2133252

  • 1. Tyrosine kinase blockers: new platelet activation inhibitors.
    Rendu F, Eldor A, Grelac F, Levy-Toledano S, Levitzki A.
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
    [Abstract] [Full Text] [Related]

  • 2. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
    Lévy-Toledano S, Grelac F, Caen JP, Maclouf J.
    Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
    [Abstract] [Full Text] [Related]

  • 3. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
    Nakashima S, Koike T, Nozawa Y.
    Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
    [Abstract] [Full Text] [Related]

  • 4. The effects of tyrphostins B42 and B46 on equine platelet function and protein tyrosine phosphorylation.
    Dillon AM, Heath MF.
    Biochem Biophys Res Commun; 1995 Jul 17; 212(2):595-601. PubMed ID: 7542881
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
    Martinson EA, Scheible S, Presek P.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul 17; 40(5):627-34. PubMed ID: 7526916
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of platelet activation by tyrosine kinase inhibitors.
    Rendu F, Eldor A, Grelac F, Bachelot C, Gazit A, Gilon C, Levy-Toledano S, Levitzki A.
    Biochem Pharmacol; 1992 Sep 01; 44(5):881-8. PubMed ID: 1382425
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
    Diaz-Ricart M, Palomo M, Fuste B, Lopez-Vilchez I, Carbo C, Perez-Pujol S, White JG, Escolar G.
    Thromb Res; 2008 Sep 01; 121(6):873-83. PubMed ID: 17904203
    [Abstract] [Full Text] [Related]

  • 8. Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein.
    Wong S, Reynolds AB, Papkoff J.
    Oncogene; 1992 Dec 01; 7(12):2407-15. PubMed ID: 1281303
    [Abstract] [Full Text] [Related]

  • 9. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M, Banno Y, Naganawa T.
    Platelets; 2005 Dec 01; 16(8):482-91. PubMed ID: 16287615
    [Abstract] [Full Text] [Related]

  • 10. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F, Bachelot C, Molle D, Caen J, Guez D.
    J Cardiovasc Pharmacol; 1993 Dec 01; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [Abstract] [Full Text] [Related]

  • 11. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
    Hargreaves PG, Licking EF, Sargeant P, Sage SO, Barnes MJ, Farndale RW.
    Thromb Haemost; 1994 Oct 01; 72(4):634-42. PubMed ID: 7878644
    [Abstract] [Full Text] [Related]

  • 12. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY, Wu YC, Wu CC.
    Mol Pharmacol; 2006 Oct 01; 70(4):1380-9. PubMed ID: 16837624
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY, Hsieh PW, Wu YC, Wu CC.
    Biochem Pharmacol; 2007 Aug 15; 74(4):601-11. PubMed ID: 17601492
    [Abstract] [Full Text] [Related]

  • 14. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA, Scheible S, Marx-Grunwitz A, Presek P.
    Thromb Haemost; 1998 Dec 15; 80(6):976-81. PubMed ID: 9869170
    [Abstract] [Full Text] [Related]

  • 15. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD, Lee IK, Lee WM, Cho JY, Park HJ, Oh JW, Park SC, Kim SK, Kwak YS, Yun BS, Rhee MH.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):361-7. PubMed ID: 18313047
    [Abstract] [Full Text] [Related]

  • 16. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
    Francischetti IM, Ghazaleh FA, Reis RA, Carlini CR, Guimarães JA.
    Arch Biochem Biophys; 1998 May 15; 353(2):239-50. PubMed ID: 9606958
    [Abstract] [Full Text] [Related]

  • 17. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
    Minuz P, Fumagalli L, Gaino S, Tommasoli RM, Degan M, Cavallini C, Lecchi A, Cattaneo M, Lechi Santonastaso C, Berton G.
    Biochem J; 2006 Nov 15; 400(1):127-34. PubMed ID: 16859489
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of thrombin-induced platelet activation by dioctanoylglycerol pretreatment is not correlated with the 47 kDa protein phosphorylation.
    Ruzzene M, Francesconi M, Cavallini L, Battistella L, Deana R.
    Second Messengers Phosphoproteins; 1992 Nov 15; 14(1-2):11-9. PubMed ID: 1403847
    [Abstract] [Full Text] [Related]

  • 19. The effects of 1-oleoyl-2-acetylglycerol on platelet protein phosphorylation and platelet ultrastructure.
    Friesen LL, Gerrard JM.
    Am J Pathol; 1985 Oct 15; 121(1):79-87. PubMed ID: 4050978
    [Abstract] [Full Text] [Related]

  • 20. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
    Asahi M, Yanagi S, Ohta S, Inazu T, Sakai K, Takeuchi F, Taniguchi T, Yamamura H.
    FEBS Lett; 1992 Aug 31; 309(1):10-4. PubMed ID: 1511739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.